Who is sponsoring NCT05664022?

NCT05664022 is sponsored by Cairo University.

What drugs are being tested in NCT05664022?

Interventions in NCT05664022: Global postural reeducation.

What condition does NCT05664022 study?

NCT05664022 studies Low Back Pain, Postural.

Is NCT05664022 still recruiting?

NCT05664022 is currently completed. Last updated 15 June 2023.

Last reviewed 2023-06-15 · How we verify

NCT05664022

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Effect of Global Postural Reeducation on Low Back Pain Patients With Lower Cross Syndrome

Completed NA Last updated 15 June 2023

What this trial tests

NA trial testing Global postural reeducation in Low Back Pain, Postural in 50 participants. Completed in 10 June 2023.

Timeline

1 January 2023

Primary endpoint
10 June 2023

10 June 2023

Quick facts

Lead sponsor	Cairo University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	treatment
Enrollment	50
Start date	1 January 2023
Primary completion	10 June 2023
Estimated completion	10 June 2023
Sites	1 location across Egypt

Drugs / interventions tested

Global postural reeducation

Conditions studied

Low Back Pain, Postural — all drugs for Low Back Pain, Postural →

Sponsor

Cairo University

Who can join

Adults 25 to 40, any sex, with Low Back Pain, Postural. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study will be conducted toinvestigate the effect of Global Postural Re-education on low back pain patients with Lower cross syndrome

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Cairo University trials

Trials by the same sponsor.

NCT04155528 — Effect of Music Therapy on Postoperative Health Outcomes · NA · not yet recruiting
NCT07363239 — CBCT-Based Safety Distance for Implant Placement Near the Inferior Alveolar Canal · not yet recruiting
NCT07374575 — Egyptian Dental Professionals' Perspectives on the Oral Microbiome and Exosomes · not yet recruiting
NCT07381153 — In-Vitro Cytotoxicity Assessment of INOX (Nanoksa G Plus) Polymer Discs · not yet recruiting
NCT07375394 — 3D-Printed Extraoral Camera for Standardized Dental Photography · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05664022 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Cairo University
Last refreshed: 15 June 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05664022.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing